Skip to main content
Home > Week in Review > Sales & Marketing

Chronological Index of : Sales and Marketing

 Current Issue
  • Kyowa Hakko Kirin, Leo Pharma sales and marketing update

    Kyowa Hakko Kirin Co. Ltd. (Tokyo:4151), Tokyo, Japan Leo Pharma A/S, Ballerup, Denmark Business: Dermatology Kyowa launched Dovobet Ointment calcipotriene/betamethasone dipropionate in Japan to treat psoriasis vulgaris…

    Published on 9/22/2014
  • Panagene sales and marketing update

    Panagene Inc., Daejeon, South Korea Business: Diagnostic Panagene launched four products integrated with the company's C-melting technology, which detects mutations from circulating tumor DNA in blood. According to …

    Published on 9/22/2014
  • AstraZeneca sales and marketing update

    AstraZeneca plc (LSE:AZN; NYSE:AZN), London, U.K. Business: Endocrine/Metabolic, Drug delivery AstraZeneca launched Bydureon Pen for self-injection of once-weekly Bydureon exenatide in the U.S. to treat Type II …

    Published on 9/15/2014
  • Biotie, Lundbeck sales and marketing update

    Biotie Therapies Corp. (HSE:BTH1V), Turku, Finland H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Neurology Biotie said partner Lundbeck launched Selincro nalmefene in Germany to reduce alcohol consumption in…

    Published on 9/15/2014
  • Boehringer Ingelheim, Eli Lilly sales and marketing update

    Boehringer Ingelheim GmbH, Ingelheim, Germany Eli Lilly and Co. (NYSE:LLY), Indianapolis, Ind. Business: Endocrine/Metabolic The pharmas launched Jardiance empagliflozin tablets in the U.S. to treat Type II diabetes. …

    Published on 9/15/2014
  • Chugai sales and marketing update

    Chugai Pharmaceutical Co. Ltd. (Tokyo:4519), Tokyo, Japan Business: Cancer Chugai launched Alecensa alectinib in Japan to treat unresectable, recurrent or advanced anaplastic lymphoma kinase (ALK)-positive non-small …

    Published on 9/15/2014
  • Ipsen sales and marketing update

    Ipsen Group (Euronext:IPN; Pink:IPSEY), Boulgne-Billancourt, France Business: Endocrine/Metabolic Ipsen said a second batch of Increlex mecasermin will be available this month to treat pediatric patients with severe …

    Published on 9/15/2014
  • LabCorp sales and marketing update

    Laboratory Corp. of America Holdings (NYSE:LH), Burlington, N.C. Business: Diagnostic LabCorp launched the informaSeq Prenatal Test to assess risk for multiple fetal chromosomal aneuploidies in maternal cell-free DNA (…

    Published on 9/15/2014
  • Pragma Pharmaceuticals sales and marketing update

    Pragma Pharmaceuticals LLC, Locust Valley, N.Y. Business: Infectious Pragma re-launched Moxatag, a once-daily, extended-release formulation of amoxicillin. The product has been approved in the U.S. since 2008 to treat …

    Published on 9/15/2014
  • Roche sales and marketing update

    Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Diagnostic Roche launched its next-generation real-time PCR cobas 6800 and 8800 systems in markets accepting the CE Mark, including Europe, Latin America, the …

    Published on 9/15/2014
  • Teva sales and marketing update

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Business: Infectious Teva launched a generic version of 0.5 and 1 mg Baraclude entecavir in the U.S. Teva said it will have 180 days of generic market…

    Published on 9/15/2014
  • Theratechnologies, Merck KGaA sales and marketing update

    Theratechnologies Inc. (TSX:TH), Montreal, Quebec Merck KGaA (Xetra:MRK), Darmstadt, Germany Business: Endocrine/Metabolic Theratechnologies said it sent a first shipment of 1 mg Egrifta tesamorelin to its U.S. …

    Published on 9/15/2014
  • Theravance Biopharma sales and marketing update

    Theravance Biopharma Inc. (NASDAQ:TBPH), South San Francisco, Calif. Business: Infectious Theravance said it has launched Vibativ telavancin in a limited number of geographic territories in the U.S during the past year…

    Published on 9/15/2014
  • Lundbeck sales and marketing update

    H. Lundbeck A/S (CSE:LUN), Copenhagen, Denmark Business: Cardiovascular H. Lundbeck launched Northera droxidopa in the U.S. to treat symptomatic neurogenic orthostatic hypotension (NOH). The wholesale acquisition cost …

    Published on 9/8/2014
  • MDxHealth sales and marketing update

    MDxHealth S.A. (Euronext:MDXH), Liege, Belgium Business: Diagnostic MDxHealth said U.S. healthcare providers Consilium LLC and the Ancillary Care Services (ACS) of American CareSource Holdings Inc. will cover MDxHealth'…

    Published on 9/8/2014
  • Ono Pharmaceutical sales and marketing update

    Ono Pharmaceutical Co. Ltd. (Tokyo:4528), Osaka, Japan Business: Cancer Ono launched Opdivo nivolumab in Japan to treat unresectable melanoma. The Japanese National Health Insurance (NHI) list price is Y728,849 ($6,996.…

    Published on 9/8/2014
  • Apricus Biosciences, Novartis sales and marketing update

    Apricus Biosciences Inc. (NASDAQ:APRI), San Diego, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Genitourinary Apricus said the Sandoz generics division of Novartis launched Vitaros alprostadil …

    Published on 9/1/2014
  • BTG sales and marketing update

    BTG plc (LSE:BTG), London, U.K. Business: Cardiovascular BTG launched Varithena in the U.S. to treat varicose veins. The wholesale acquisition cost (WAC) for a 45 mL tube of 10 mg/mL Varithena is $3,195. The polidocanol…

    Published on 9/1/2014
  • Cubist sales and marketing update

    Cubist Pharmaceuticals Inc. (NASDAQ:CBST), Lexington, Mass. Business: Infectious Cubist launched an IV formulation of Sivextro tedizolid in the U.S. to treat acute bacterial skin and skin structure infections (ABSSSIs) …

    Published on 9/1/2014
  • GlaxoSmithKline sales and marketing update

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Endocrine/Metabolic GlaxoSmithKline launched Tanzeum albiglutide in the U.S. to treat Type II diabetes as monotherapy or as add-on therapy. The wholesale …

    Published on 9/1/2014
  • Invitae sales and marketing update

    Invitae Corp., San Francisco, Calif. Business: Diagnostic Invitae launched PALB2 testing worldwide to diagnose cancer. The test includes full sequencing and deletion/duplication analysis of the partner and localizer of …

    Published on 9/1/2014
  • MolecularHealth sales and marketing update

    MolecularHealth Inc., The Woodlands, Texas Business: Bioinformatics, Pharmacogenetics MolecularHealth introduced MolecularHealth RxAssistance as a component of its TreatmentMAP offering in the U.S. MolecularHealth …

    Published on 9/1/2014
  • Protagen sales and marketing update

    Protagen AG, Dortmund, Germany Business: Proteomics Protagen launched ADx SSc Multilisa in the EU and North America to research scleroderma. The qualitative ELISA-based test kit uses Protagens SeroTag biomarker platform…

    Published on 9/1/2014
  • Sanofi, Program for Appropriate Technology in Health sales and marketing update

    Sanofi (Euronext:SAN; NYSE:SNY), Paris, France Program for Appropriate Technology in Health (PATH), Seattle, Wash. Business: Infectious Sanofi and PATH began delivering the first large-scale batches of antimalarial …

    Published on 9/1/2014
  • BGI sales and marketing update

    BGI, Shenzhen, China Business: Genomics, Supply/Service BGIs BGI Tech Solutions Co. Ltd. subsidiary launched a human whole exome sequencing service using its Complete Genomics Inc. subsidiarys technology. The worldwide …

    Published on 8/18/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993